UltraGreen.ai gains Singapore approval for Verdye in regional push

The regulatory clearance anchors UltraGreen.ai's Southeast Asia expansion.

UltraGreen.ai has secured regulatory approval in Singapore for Verdye, or indocyanine green for injection, which will support its expasion in Southeast Asia.

In a press release, the company said the approval gives the company access to Singapore’s healthcare system, noting Singapore acts as a centre for clinical practice and regional influence in healthcare adoption.

The approval also supports its commercialisation efforts and partnerships with hospitals and healthcare institutions in the city-state.

Verdye is used in fluorescence-guided surgery with indocyanine green, applied in oncology, colorectal, reconstructive, and vascular procedures.

UltraGreen.ai develops a fluorescence-guided surgery platform combining pharmaceutical products, imaging hardware, and artificial intelligence-based data tools for surgical decision-making and procedural standardisation.

The company said the platform supports wider adoption of fluorescence-guided surgery across procedures.

Ravi Sajwan, CEO of UltraGreen.ai, said Singapore serves as a strategic market due to its healthcare system and regional role in clinical adoption across Southeast Asia, adding that the approval supports regulatory execution and the company’s regional strategy.

Verdye is approved in 41 countries, whilst the IC-Flow imaging system is approved in 45 markets.

UltraGreen.ai also referenced its recent initial public offering and regulatory approval of Verdye in the Philippines as part of its Southeast Asia expansion.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia